Literature DB >> 32005060

Analysis of risk factors for implantable venous access port catheter fracture with internal jugular vein.

Ning Ai1, Li Li1, Fenghua Yin1, Zhigang Li1, Cuizhi Geng2, Guang Yang3.   

Abstract

BACKGROUND: To investigate the risk factors of the in vivo implantable venous access port (IVAP) catheter fracture.
METHODS: We retrospectively analyzed 3,102 cases of patients with vascular access devices from November 2013 to March 2016 in the hospital by PACS. The clinical and radiographic features (age, occupation, living habit, IVAP duration, intravascular outer catheter angle, location of catheter tip and IVAP implantation site) were summarized to analyze the related risk factors of fracture in the 3,102 patients.
RESULTS: There were 15 cases of fracture in 3,102 patients, and the fracture site were located at the entrance of the internal jugular vein (IJV) (n=12), the outlet of the vascular access devices (n=1), the distal portion of the catheter (n=2). Fracture was closely related to the factors of port time, age and occupation, but not related to the location of the port, the position of the catheter tip and the angle of the inner and the outer catheter. Age and IVAP duration were an independent risk factor for IVAP catheter fracture.
CONCLUSIONS: Implantable vascular access devices are approved by its advantages of being safe, effective and less invasive. It is important to clarify the related factors and early prevention of fracture.

Entities:  

Keywords:  In vivo implantable venous access port catheter (in vivo IVAP catheter); breast cancer; catheter fracture; high-risk factors; internal jugular vein (IJV)

Mesh:

Year:  2020        PMID: 32005060     DOI: 10.21037/apm.2019.12.04

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  1 in total

1.  Risk Factors of Catheter-Related Infection in Unplanned Extubation of Totally Implantable Venous-Accessportsin Tumor Patients.

Authors:  Min Xu; Lie Deng; Yanyi Zhu; Yuanfang Li; Fan Wang; Hui Li; Ying Zhou
Journal:  Emerg Med Int       Date:  2022-09-27       Impact factor: 1.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.